Heidelberg Pharma AG (ETR:HPHA) | WebDisclosure

Basculer en Français

10084	Companies
206250	Keywords
136472	Articles
109346	Press releases

Home
Companies
Heidelberg Pharma AG

PRESS RELEASE

published on 08/28/2025 at 03:50, 6 months 28 days ago

EQS-Adhoc: Heidelberg Pharma’s Partner Telix Pharmaceuticals Gives Regulatory Update for its Imaging Agent TLX250-CDx
Heidelberg Pharma's partner Telix Pharmaceuticals faces delays in TLX250-CDx FDA approval. USD 70 million payment from HealthCare Royalty postponed. Current cash reach until Q1 2026

FDA Approval Heidelberg Pharma HealthCare Royalty Telix Pharmaceuticals TLX250-CDx
BRIEF

published on 07/10/2025 at 07:08, 8 months 15 days ago

Développements prometteurs de Heidelberg Pharma pour la mi-année 2025

Changements De Direction Évolution Financière Accord De Redevances Essais HDP-101 Présentation Du HDP-102
BRIEF

published on 07/10/2025 at 07:08, 8 months 15 days ago

Heidelberg Pharma's Promising Mid-Year 2025 Developments

Leadership Changes Royalty Agreement Financial Developments HDP-101 Trials HDP-102 Introduction
PRESS RELEASE

published on 07/10/2025 at 07:03, 8 months 15 days ago

Heidelberg Pharma Reports on First Half-Year 2025 and the Positive Course of Business
Heidelberg Pharma AG reports on positive first half-year 2025 business performance including advancements in ATAC candidates HDP-101 and HDP-102. Financial figures show promising results in line with planning

Financial Report Clinical Trials HDP-101 Heidelberg Pharma AG ATAC Candidates
BRIEF

published on 05/27/2025 at 08:12, 9 months 29 days ago

Heidelberg Pharma lance une étude de phase I pour le HDP-102 dans le lymphome non hodgkinien

Heidelberg Pharma Technologie ADC HDP-102 Lymphome Non Hodgkinien Étude De Phase I
BRIEF

published on 05/27/2025 at 08:12, 9 months 29 days ago

Heidelberg Pharma Begins Phase I Study for HDP-102 in Non-Hodgkin Lymphoma

Heidelberg Pharma ADC Technology HDP-102 Non-Hodgkin Lymphoma Phase I Study
PRESS RELEASE

published on 05/27/2025 at 08:07, 9 months 29 days ago

Heidelberg Pharma Announces First Patient Dosed in Phase I Study of Amanitin-based ADC Candidate HDP-102 for Non-Hodgkin Lymphoma
Heidelberg Pharma dosed first patient in Phase I study of Amanitin-based ADC HDP-102 for Non-Hodgkin Lymphoma. ATAC technology targeting CD37. Promising data presented at AACR 2024

Heidelberg Pharma ATAC Technology Amanitin-based ADC Non-Hodgkin Lymphoma Phase I Study
BRIEF

published on 05/15/2025 at 14:36, 10 months 9 days ago

Heidelberg Pharma Announces AGM Results and New Supervisory Board

Supervisory Board Biotech Heidelberg Pharma ADCs AGM 2025
BRIEF

published on 05/15/2025 at 14:36, 10 months 9 days ago

Heidelberg Pharma annonce les résultats de son assemblée générale annuelle et la création d'un nouveau conseil de surveillance

Biotechnologie Conseil De Surveillance Heidelberg Pharma ADC Assemblée Générale Annuelle 2025
PRESS RELEASE

published on 05/15/2025 at 14:31, 10 months 9 days ago

Heidelberg Pharma Reports on the Results of the Ordinary Annual General Meeting 2025 and New Supervisory Board
Heidelberg Pharma AG reports on the results of the Ordinary Annual General Meeting 2025 and the appointment of a new Supervisory Board. Key decisions made include new board members and Dr. Karl Benedikt Biesinger elected as Chairman

Annual General Meeting Supervisory Board Heidelberg Pharma AG ADCs Dr. Karl Benedikt Biesinger

Accesswire

Published on 03/25/2026 at 08:01, 1 hour 6 minutes ago

Apex Critical Metals Appoints Zayn Kalyan to Board of Directors
Published on 03/25/2026 at 04:50, 4 hours 17 minutes ago

Arctic Fox Announces Closing of First Tranche of Non-Brokered Private Placement
Published on 03/24/2026 at 23:42, 9 hours 25 minutes ago

Presentation to Gold Coast Gold Conference
Published on 03/24/2026 at 23:00, 10 hours 7 minutes ago

Redwood AI Selected to Present at BIO-Europe Spring 2026, Europe's Largest Springtime Biotech Partnering Event
Published on 03/24/2026 at 18:55, 14 hours 12 minutes ago

Norse Gold Announces Closing of Private Placement Financing and Pending Reactivation on the TSX-V

View all ACCESSWIRE

EQS Group

Published on 03/25/2026 at 08:40, 27 minutes ago

UnionPay International Sponsors THE MONSTERS 10th Anniversary Global Tour Paris Stop
Published on 03/25/2026 at 08:30, 37 minutes ago

FRIWO meets its targets 2025 and achieves a significant improvement in earnings as well as a strengthened financial position
Published on 03/25/2026 at 08:30, 37 minutes ago

ASTA Energy Solutions AG establishes a strong leadership structure for its growth trajectory
Published on 03/25/2026 at 08:30, 37 minutes ago

According to preliminary figures, 2G Energy AG continues to chart its significant growth course in new equipment business (approx. EUR 230 million, previous year: EUR 207.3 million, +11%)
Published on 03/25/2026 at 08:05, 1 hour 2 minutes ago

Nota AI and SiMa.ai Sign Strategic Partnership for Physical AI Technology Collaboration

Les Echos

Published on 03/25/2026 at 08:45, 22 minutes ago

Air Liquide inaugurates its first Advanced Materials manufacturing plant in Taiwan, strengthening the next-gen semiconductor supply chain
Published on 03/25/2026 at 08:45, 22 minutes ago

Air Liquide inaugure sa première usine de production de Matériaux Avancés à Taïwan, renforçant ainsi la chaîne d'approvisionnement en semi-conducteurs de nouvelle génération
Published on 03/25/2026 at 07:00, 2 hours 7 minutes ago

TINC invests in large-scale battery storage to strengthen the flexibility of the Belgian electricity network (B)
Published on 03/25/2026 at 07:00, 2 hours 7 minutes ago

TINC investeert in grootschalige batterijopslag ter versterking van de flexibiliteit van het Belgische stroomnetwerk (B)
Published on 03/25/2026 at 07:00, 2 hours 7 minutes ago

TINC invests in large-scale battery storage to strengthen the flexibility of the Belgian electricity network (B)

View all LES ECHOS COMFI WIRE